Biomarker Expression in Head and Neck Squamous Cell Carcinoma – Implications for Therapy


Rebecca Feldman, Ph.D., Ariane Kemkes, Ph.D., Joanne Xiu, Ph.D., David Arguello, M.D., Gargi Basu, Ph.D., Richard Blevins, Ph.D., Raheela Ashfaq, M.D., Zoran Gatalica, M.D., DSc., David Loesch, M.D., Richard Bender, M.D.


Head and neck squamous cell carcinoma (HNSCC) is an aggressive disease with an unpredictable prognosis. Failure of first-line treatment is common, thus additional therapeutic options are in great need. The purpose of this study was to explore biomarker expression profiles of HNSCC for therapeutic strategies that are not commonly pursued.

Download Publication